The China Association of Clinical Laboratory Practice Expo (CACLP) and the China IVD Supply Chain Expo (CISCE) are back with a bang, set to take place from March 16-18 at the Chongqing International Expo Center. This year, the event promises to be bigger and better than ever, with over 1,300 exhibitors from 19 countries and regions showcasing their latest offerings.
The 21st edition of CACLP and the 4th edition of CISCE are expected to build upon the success of previous years, with a record-breaking gathering of approximately 40,000 visitors from 29 countries and regions in 2023. This year, the event returns to the vibrant city of Chongqing, known for its impressive landscapes, thriving academic community, cutting-edge technological development, and robust economic growth.
Chongqing, as the most populated city and the fourth-largest economic hub in China, is home to 32.13 million residents and abundant medical resources, making it the perfect backdrop for an event that fosters collaboration and innovation in the field of in vitro diagnostics (IVD).
CACLP & CISCE 2024 aim to establish quality networking and facilitate meaningful connections that drive innovation forward, under the slogan “Shaping A Smarter Future Through Collaboration.”
Major Academic Sessions
The event kicks off on March 15 with The 9th China Experimental Medicine Conference (CEMC), featuring speeches by Chinese and international academicians, as well as renowned experts and scholars in experimental medicine and biomedical engineering. The conference will cover topics such as advanced hospital management, innovative medical models, and the implementation of the Healthy China strategy.
On March 16, over 10 series sessions will be held, covering topics ranging from intelligent medicine to laboratory management, providing attendees with a comprehensive overview of the latest developments in the field of experimental medicine.
The 11th China IVD Industry Development Conference (CIIDC) will focus on new trends and developments in the IVD industry, with discussions on how to build a healthy industry ecosystem and promote its benign development. The conference will cover topics such as IVD health economics, innovation, and investment and financing, providing attendees with valuable insights into the future of the industry.
The 6th China IVD Distribution Enterprise Forum (CIDEF) will host discussions on the service ethos, quality control, and developmental experiences of IVD distribution enterprises, providing attendees with practical knowledge and insights into the industry.
Enlightening Lab Med – The 7th IVD Youth Entrepreneur Forum (ELM·Y) will provide young entrepreneurs with a platform to strengthen their industrial innovation and enhance their comprehensive capabilities, with insights from industry experts and senior investment banking partners.
The 4th China Key Raw Material & Parts Forum (CKRMPF) will invite industry leaders and experts to discuss industry topics and future plans, providing attendees with valuable insights into the future of the industry.
International Engagement Highlights
This year’s event will also feature a series of international engagements, with representatives from 18 countries and regions, including Canada, Germany, India, Italy, Japan, Korea, and the USA, confirmed as exhibitors and academic contributors.
International exhibitors will present their latest developments and new products during engaging roadshows, facilitating global networking opportunities.
CEMC and its series sessions, CIIDC and its series forums, and the IFCC International Laboratory Medicine & IVD Forum will welcome a delegation of international scientists to share the most developed technology and deliver informative reports to the local industry and community.
CACLP & CISCE 2024 welcome industry professionals from around the world to join us for an experience filled with innovative exhibits, groundbreaking research presentations, insightful discussions, and networking opportunities. Join us in Chongqing to gain access to new content and find inspiration that drives IVD progress.
